THE NURSES ROLE IN PEPTIDE RECEPTOR RADIONUCLIDE THERAPY (PRRT) WITH LUTATHERA

被引：0
|
作者：
Longing, Anne [1 ]
Boswell, Abigail [1 ]
Kennedy, Matthew [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
来源：
ONCOLOGY NURSING FORUM | 2019年 / 46卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
29
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Amino Acid Solutions in Premedication Peptide Receptor Radionuclide Therapy (PRRT) with Lutathera®: a Tolerance Study
    Courault, P.
    Habouzit, V.
    Deville, A.
    Mele, L.
    Bouzehouane, N.
    Bour, F.
    Levigoureux, E.
    Bolot, C.
    Bournaud, C.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S91 - S92
  • [2] Peptide Receptor Radionuclide Therapy (PRRT): Innovations and Improvements
    Merola, Elettra
    Grana, Chiara Maria
    [J]. CANCERS, 2023, 15 (11)
  • [3] Comparison of Four Infusion Methods for Lutathera Peptide Radionuclide Receptor Therapy
    Ellis, Anne
    Lawson, Susan
    Rybicki, Lauren
    Ackermann, Robert
    Newton, Regen
    Frey, Kirk
    Wong, Ka Kit
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2021, 62
  • [4] The technologist role in 177Lu dosimetry for PRRT (Peptide Receptor Radionuclide Therapy)
    Leoni, E.
    Filice, A.
    Palmieri, A.
    Ghiraldini, G.
    Fioroni, F.
    Grassi, E.
    Cola, S.
    Versari, A.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S850 - S851
  • [5] Kidney protection during peptide receptor radionuclide therapy (PRRT)
    Melis, M.
    Rolleman, E. J.
    Vegt, E.
    Gotthardt, M.
    Oyen, W. G. J.
    Krenning, E. P.
    Boerman, O. C.
    de Jong, M.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S206 - S206
  • [6] Peptide receptor radionuclide therapy (PRRT) for GEP-NETs
    Bergsma, Hendrik
    van Vliet, Esther I.
    Teunissen, Jaap J. M.
    Kam, Boen L. R.
    de Herder, Wouter W.
    Peeters, Robin P.
    Krenning, Eric P.
    Kwekkeboom, Dik J.
    [J]. BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2012, 26 (06) : 867 - 881
  • [7] Metastatic Medullary Thyroid Cancer (MTC): Is There a Role for Peptide Receptor Radionuclide Therapy (PRRT)?
    Hayes, A. R.
    Crawford, A.
    Al Riyami, K.
    Tang, C.
    Wild, D.
    Khoo, B.
    Caplin, M.
    Nicolas, G.
    Grossman, A. B.
    [J]. NEUROENDOCRINOLOGY, 2019, 108 : 273 - 273
  • [8] Kidney protection during peptide receptor radionuclide therapy (PRRT)
    Melis, Marleen
    Rolleman, Edgar J.
    Vegt, Erik
    Gotthardt, M.
    Oyen, Wim J. G.
    Krenning, Eric P.
    Boerman, Otto C.
    De Jong, Marion
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2009, 50
  • [9] Peptide receptor radionuclide therapy (PRRT) - current state and innovative developments
    Baum, R. P.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 297 - 297
  • [10] Differences in pretherapeutic and therapeutic biodistributions in peptide receptor radionuclide therapy (PRRT)
    Kletting, P.
    Mueller, B.
    Schmaljohann, J.
    Behrendt, F. F.
    Reske, S. N.
    Mottaghy, F. M.
    Glatting, G.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S351 - S351
12345